• Angiotensin II, Ferroptosis, and NPC Radioresistance

  2026-09-23

  A study in nasopharyngeal carcinoma links locally produced angiotensin II to radioresistance through an AGT–HIF-1α–HILPDA circuit that limits ferroptosis. Its findings support investigating angiotensin receptor blockade alongside ferroptosis induction, while the proposed pathway biomarkers and treatment strategy still require clinical validation.

• Firefly Luciferase mRNA as a Translation Benchmark

  2026-09-23

  Firefly Luciferase mRNA can do more than generate a bright reporter signal: it can help separate delivery, translation, and protein-function variables. This article connects the R1013 design with chemically modified mRNA research and provides a decision framework for reproducible assay interpretation.

• CX-5461 RNA Polymerase I Inhibitor Workflow

  2026-09-22

  Build a mechanism-led CX-5461 workflow that links Pol I-driven rRNA suppression with DNA damage, mitotic catastrophe, autophagy, and senescence. Practical formulation, assay-selection, combination-testing, and troubleshooting guidance supports reproducible cancer research from cultured cells to solid-tumor models.

• Nuclear cGAS and L1 Retrotransposition Control

  2026-09-22

  The reference study identifies nuclear cGAS as a genome-protective suppressor of LINE-1 retrotransposition, acting through CHK2-dependent recruitment of the E3 ligase TRIM41 and degradation of ORF2p. Its findings connect DNA damage signaling, transposable-element control, senescence, and cancer-associated cGAS mutations, while providing a mechanistic framework for future DNA damage response studies.

• L1023 Anti-Cancer Compound Library for Cancer Research

  2026-09-21

  The L1023 Anti-Cancer Compound Library provides 1164 pre-dissolved bioactive compounds for cancer research and high-throughput screening. Its pathway coverage supports comparative studies of BRAF kinase inhibitor activity, mTOR signaling pathway regulation, apoptosis, and other oncogenic processes.

• AZ505: A Practical SMYD2 Inhibitor Workflow

  2026-09-21

  AZ505 enables substrate-competitive interrogation of SMYD2 across biochemical, cellular, cancer, and renal-fibrosis models. This workflow combines assay design, concentration optimization, orthogonal readouts, and troubleshooting guidance to distinguish pathway modulation from nonspecific toxicity.

• AZ505: A Selective SMYD2 Inhibitor for Cell Studies

  2026-09-20

  AZ505 combines substrate-competitive SMYD2 inhibition with strong enzyme selectivity, making it useful for connecting methyltransferase biochemistry to cellular phenotypes. This practical guide covers assay design, renal fibrosis translation, cancer biology research, and troubleshooting for reproducible experiments.

• CX-5461: From Pol I Stress to Cell Fate

  2026-09-19

  CX-5461 is an RNA polymerase I inhibitor that links rRNA transcriptional stress with DNA damage, mitotic catastrophe, autophagy, and senescence. This article presents a phenotype-resolved framework for selecting assays and interpreting responses across solid tumor models.

• Epalrestat Neuroprotection in Parkinson’s Disease

  2026-09-18

  Jia et al. report that the established aldose reductase inhibitor Epalrestat protects dopaminergic neurons in cellular and mouse Parkinson’s disease models by engaging KEAP1, activating Nrf2, and reducing oxidative and mitochondrial stress. The findings provide a mechanistic basis for drug repurposing, while the toxin-based, short-term, and pretreatment-centered design leaves clinical translation unresolved.

• 5-Azacytidine: From Demethylation to DNA Damage

  2026-09-18

  5-Azacytidine is more than a DNA methyltransferase inhibitor. By trapping DNMT enzymes, 5-AzaC links epigenetic reprogramming to replication stress, ATR-mediated DNA damage, and apoptosis. This thought-leadership guide translates the multiple myeloma evidence into a practical framework for leukemia models, combination studies, assay design, and translational decision-making.

• Cholesterol Hinders Intracellular LNP Trafficking

  2026-09-17

  Luo and colleagues developed a streptavidin–biotin–DNA tracking and high-throughput imaging platform to examine how lipid nanoparticle composition affects intracellular trafficking. Their results indicate that increasing cholesterol, rather than ionizable lipid content alone, promotes accumulation of LNP–nucleic acid cargo in peripheral early endosomes and reduces progression toward compartments associated with cargo release.

• Pentoxifylline and Preterm Monocyte Hyperinflammation

  2026-09-17

  Schüller et al. developed an in vitro comparison of LPS-stimulated monocytes from preterm infants, term infants, and adults to define age-dependent responses to pentoxifylline. The study shows that pentoxifylline suppresses inflammatory cytokines, TLR4 expression and signaling, surface activation markers, and phagocytosis, while also revealing distinct neonatal effects on CD14, CD11b, and early IL-10 production.

• Microglia, Synapses, and Alcohol-Induced Seizures

  2026-09-16

  The reference study identifies hippocampal CA1 microglial activation as a mechanistic link between acute alcohol exposure, synaptic remodeling, and increased seizure susceptibility. Its minocycline intervention supports a causal role for microglia, while also highlighting the need to distinguish synapse number from functional network inhibition.

• JNJ-10198409 PDGF Receptor Assay Guide

  2026-09-16

  This scenario-based guide explains how JNJ-10198409 (SKU C5737) can support PDGF-BB receptor inhibition studies involving cell proliferation, viability, angiogenesis, and cytotoxicity readouts. It combines product-documented potency, solubility, storage, and handling information with practical controls for more interpretable laboratory workflows.

• Myriocin Workflow for Sphingolipid Research

  2026-09-15

  Use Myriocin to connect SPT activity with ceramide production, apoptosis, cell growth, and pathway remodeling in a controlled experimental workflow. The approach combines dose-response design, orthogonal lipid and phenotype assays, and the SPTLC2-centered cardiovascular mechanism highlighted by recent research.

8414 records 1/561 page Next 12345 下5页 Last page